Zai Lab Limited ( ZLAB) - Key Metrics
ZLAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.95 | -$0.46 | -$0.41 | -$0.42 |
| 2026Q1 | $0.90 | -$0.46 | -$0.11 | -$0.31 |
| 2025Q4 | $1.15 | -$0.46 | -$0.24 | -$0.25 |
| 2025Q3 | $1.05 | -$0.33 | -$0.29 | -$0.33 |
| 2025Q2 | $1.01 | -$0.37 | -$0.28 | -$0.29 |
ZLAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.50 |
| 2026Q1 | 0% | -9.41 |
| 2025Q4 | 0% | -9.59 |
| 2025Q3 | 0% | -25.67 |
| 2025Q2 | 0% | -23.38 |
ZLAB
Price: $23.65
52 week price:
Earnings Per Share: -1.70 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 84585
Market Capitalization: 2.7 billion